Evidence map›Paper›PMID 15215378›Full record

ArticleNucleic acids research2004

PromoSer: improvements to the algorithm, visualization and accessibility.

Anason S Halees, Zhiping Weng

Abstract read
In one paragraph

Article in Nucleic acids research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Rapid identification of novel functional promoters for gene therapy.Journal of molecular medicine (Berlin, Germany) · 2012
    Article
  3. Article
  4. Article
  5. Article
  6. Promoter analysis: gene regulatory motif identification with A-GLAM.Methods in molecular biology (Clifton, N.J.) · 2009
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anason S HaleesBioinformatics Program, Boston University, 44 Cummington Street, Boston, MA 02215, USA.
Zhiping Weng

Funding

Alternative Promoter Usage in Tissue-specific Gene Expr*R01HG003110 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WENG, ZHIPING · 2003 to 2006
$1.9M
PERTURBATION ANALYSIS OF PI3 KINASE /ERK SIGNALINGP20GM066401 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DELISI, CHARLES · 2002 to 2004
$1.2M
NHGRI NIH HHS R01 HG003110NIGMS NIH HHS P20 GM066401
6 · The paper itself

Abstract

PromoSer is a web service that provides an easy and efficient approach to the batch retrieval of a large number of proximal promoters. Since its introduction last year, it has undergone continued development and expansion. At the core, there have been improvements in the filtering of the raw mRNA/EST sequences upon which all predictions are built, improvements in the alignments clustering and transcription start site prediction algorithms, and improvements in the backing database for increased performance. At the user interface level, improvements include enhanced functionality and user options, better integration with other resources on the web and a new visualization tool. PromoSer now also supports queries using a SOAP-based interface and XML-based responses. The service is publicly available at http://biowulf.bu.edu/zlab/PromoSer.

Indexed as

AlgorithmsPromoter Regions, GeneticSoftwareAnimalsComputer GraphicsExpressed Sequence TagsHumansInternetMiceRatsRNA, MessengerSequence AlignmentSequence AnalysisTranscription Initiation SiteUser-Computer InterfaceRNA, Messenger

Identifiers

PMID15215378
PMCPMC441571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.